About Us
Biotech Consortium India Limited (BCIL) is a public limited company, promoted by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and set up by All India Financial Institutions including IDBI, ICICI, IFCI, UTI and IFCI Venture Capital Funds Limited.
BCIL was incorporated under the Companies Act 1956(Now Company Act, 2013) in 1990 with government in advisory role, development banks as major funding agency.
It is a nodal agency for providing business support services to facilitate accelerated commercialization of biotech products and processes.
The company was inaugurated in 1990 by the then Prime Minister of India, Hon’ble Shri Chandra Shekhar, in presence of the Finance Minister, Shri. Yashwant Sinha and Dr. Manju Sharma, Secretary, Department of Biotechnology.
Read MoreLaunch of the New Public Portal For "Conference, Travel, Exhibition and Popular Lectures (CTEP)
Launch of the New Public Portal For "Conference, Travel, Exhibition and Popular Lectures (CTEP) of Department of Biotechnology, (DBT), Ministry of Science and Technology, Government of India, being managed by Biotech Consortium India Limited (BCIL) by Dr. Renu Swarup, Secretary, DBT on 14th June, 2018.
WHAT'S NEW
The panel discussed the movement of biomedical innovations from research labs to real world while emphasizing on the fact that successful technology transfer depends on a multitude of factors such as scalability, market readiness, procurement options, and clear healthcare need. The discussion focused on addressing funding and structural challenges, focusing on market problems, and building scalable solutions to ensure biomedical innovations translate into meaningful healthcare outcomes.
Technology Transfer Office (TTO) at BCIL successfully transferred a promising technology, “Green compounding technology for production of antibacterial polymer nanocomposites” developed at the Govind Ballabh Pant University of Agriculture & technology (GBPUAT), Pantnagar. This technology involves the preparation of antibacterial polymers via a green compounding technology in supercritical fluids with varied applications. It has been developed by Prof.
BCIL was invited to conduct a sensitization session for faculty members, students, and start-up stakeholders on “IP Essentials for Research-Driven Start-ups” during a Bootcamp organized by Dr. Bansi Dhar Institute on 5th Feb 2026. Dr. Nidhi Chaubey, Sr. IP Manager, BCIL, delivered presentation focusing on key aspects of IP relevant to start-ups, government funding schemes for start-ups and factors contributing towards strengthening the entrepreneurship ecosystem.